These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 35991469)
1. Cystic fibrosis liver disease in Newfoundland and Labrador: a prevalence study. Squirell E; Lockyer J Can Liver J; 2021; 4(1):33-37. PubMed ID: 35991469 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and characteristics of cystic fibrosis liver disease: a study highlighting the lack of histological diagnosis. Issa Z; Gohy S; Zech F; Baldin P; Delire B; Dahlqvist G Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101977. PubMed ID: 35772685 [TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic risk factors for cystic fibrosis-related liver disease in Egyptian CF children: A single-center experience. El-Faramawy A; Nasr SZ; Emam MMSA; Fahmy HMH Pediatr Pulmonol; 2024 Feb; 59(2):465-471. PubMed ID: 38038166 [TBL] [Abstract][Full Text] [Related]
4. Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools. Scott JA; Jones AM; Jokl E; Gordon-Walker T; Barry PJ; Hanley NA; Piper Hanley K; Athwal VS Heliyon; 2023 Nov; 9(11):e21861. PubMed ID: 38053913 [TBL] [Abstract][Full Text] [Related]
6. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population. Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979 [TBL] [Abstract][Full Text] [Related]
7. Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity. Koh C; Sakiani S; Surana P; Zhao X; Eccleston J; Kleiner DE; Herion D; Liang TJ; Hoofnagle JH; Chernick M; Heller T Hepatology; 2017 Aug; 66(2):591-601. PubMed ID: 28422310 [TBL] [Abstract][Full Text] [Related]
8. Cystic Fibrosis Liver Disease: Know More. Al Sinani S; Al-Mulaabed S; Al Naamani K; Sultan R Oman Med J; 2019 Nov; 34(6):482-489. PubMed ID: 31745411 [TBL] [Abstract][Full Text] [Related]
10. Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores. Karlas T; Neuschulz M; Oltmanns A; Güttler A; Petroff D; Wirtz H; Mainz JG; Mössner J; Berg T; Tröltzsch M; Keim V; Wiegand J PLoS One; 2012; 7(7):e42139. PubMed ID: 22848732 [TBL] [Abstract][Full Text] [Related]
11. The natural history of cystic fibrosis liver disease a prospective cohort study. Rowland M; Drummond J; Connolly L; Daly E; McCormick PA; Bourke B; ; J Cyst Fibros; 2023 Nov; 22(6):1054-1061. PubMed ID: 37495468 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis. Calvopina DA; Chatfield MD; Weis A; Coleman MA; Fernandez-Rojo MA; Noble C; Ramm LE; Leung DH; Lewindon PJ; Ramm GA Hepatology; 2018 Dec; 68(6):2301-2316. PubMed ID: 30014495 [TBL] [Abstract][Full Text] [Related]
13. The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study. Dajti E; Ravaioli F; Paiola G; Volpi S; Colecchia L; Ferrarese A; Alemanni LV; Cusumano C; Di Biase AR; Marasco G; Vestito A; Festi D; Rautou PE; Cipolli M; Colecchia A Liver Int; 2023 Nov; 43(11):2492-2502. PubMed ID: 37724776 [TBL] [Abstract][Full Text] [Related]
14. The Efficacy of MRI in the diagnostic workup of cystic fibrosis-associated liver disease: A clinical observational cohort study. Poetter-Lang S; Staufer K; Baltzer P; Tamandl D; Muin D; Bastati N; Halilbasic E; Hodge JC; Trauner M; Kazemi-Shirazi L; Ba-Ssalamah A Eur Radiol; 2019 Feb; 29(2):1048-1058. PubMed ID: 30054796 [TBL] [Abstract][Full Text] [Related]
15. Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis. Sadler MD; Crotty P; Fatovich L; Wilson S; Rabin HR; Myers RP Can J Gastroenterol Hepatol; 2015 Apr; 29(3):139-44. PubMed ID: 25855877 [TBL] [Abstract][Full Text] [Related]
16. Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients. Boëlle PY; Debray D; Guillot L; Clement A; Corvol H; Hepatology; 2019 Apr; 69(4):1648-1656. PubMed ID: 30058245 [TBL] [Abstract][Full Text] [Related]
17. Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis. Scott J; Jones AM; Piper Hanley K; Athwal VS Aliment Pharmacol Ther; 2022 Feb; 55(4):389-400. PubMed ID: 35048397 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of noninvasive markers for the diagnosis of cystic fibrosis liver disease. Alexopoulou A; Pouriki S; Vasilieva L; Alexopoulos T; Filaditaki V; Gioka M; Diamantea F; Dourakis SP Scand J Gastroenterol; 2018 Dec; 53(12):1547-1552. PubMed ID: 30600723 [TBL] [Abstract][Full Text] [Related]